Protecting, maintaining, restoring and boosting a healthy immune system from childhood to old age.
ImmuneHealthXL
ImmuneHealthXL aims to become the national public-private partnership for translational immunology research and development. Our mission is to improve immune health and enhance quality of life for all individuals affected by immune mediated inflammatory diseases by developing innovative approaches cross disease research.
News
-
ImmuneHealth-4-All awarded €6.6 million to accelerate disease-overarching innovation in immune diseases
The ImmuneHealth-4-All programme has been awarded €6.6 million in funding through the Health~Holland PPS programme to stimulate public-private partnerships. The programme stems from ImmuneHealthXL (IHXL), a national initiative promoting disease-overarching immunological research in immune-mediated inflammatory diseases (IMIDs). -
How do you explain complex immune research to patients, families, and the wider public?
IHXL researcher and Radboudumc rheumatologist Rogier Thurlings found a powerful answer: by co-creating a cartoon book with his 10-year-old son Valentijn in close collaboration with patients and patient organizations. -
Moonshot webinars are now available
At the heart of ImmuneHealthXL's strategy are four ambitious moonshots. In the ImmuneHealthXL Moonshot webinar, the moonshots are introduces and explained by experts in the field.
Our sponsors
